Bylenta 40mg Tablet
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg)
Overview Bylenta 40mg Tablet
Cardiovasc 40mg tablets manage hypertension and heart failure, reducing the risk of strokes and heart attacks. It also safeguards kidney function in diabetic patients. Prescribed alone or with other medications, this tablet can be taken with or without food, ideally at the same time daily for optimal results. Continuous use is crucial, even with controlled blood pressure, as symptoms may be absent despite the condition worsening upon cessation. Generally safe for long-term use, it's a widely accepted treatment. Lifestyle modifications – such as exercise, weight loss, smoking cessation, reduced alcohol, and a lower-sodium diet (as per doctor's advice) – further enhance its effectiveness. While generally well-tolerated, hypotension may occur. Report any side effects; dosage adjustments or alternative medications may be considered. Inform your physician of kidney or liver issues before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Regular monitoring of kidney function, blood pressure, and potassium levels is standard practice during treatment.
Uses of Bylenta 40mg Tablet
Managing elevated blood pressure | Addressing heart failure | Reducing fever | Cardiovascular event prevention
Major Benefits of Bylenta 40mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bylenta 40mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Bylenta 40mg Tablet:
- Diarrhea
- Upper respiratory tract infection
- Back pain
- Sinus inflammation
- Skin ulcer
- Intermittent claudication
How to use Bylenta 40mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bylenta 40mg tablets can be consumed with or without food, though consistent timing is recommended.
How Bylenta 40mg Tablet works:
Bilenzia 40mg tablets function as an angiotensin II receptor antagonist, widening blood vessels. This effect stems from its inhibition of a vasoconstricting substance, resulting in reduced blood pressure and improved blood flow throughout the body, including the heart.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bylenta 40mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of the medication Bylenta 40mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bylenta 40mg tablets with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 40mg Bylenta tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Bylenta 40mg tablets, as dose modification may be necessary. It's crucial to seek medical advice. Pre-existing kidney disease should be disclosed to your physician. Your doctor might recommend routine monitoring of blood pressure, creatinine, and potassium levels during treatment.
LiverCAUTION
Patients with liver impairment should use Bylenta 40mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated for individuals with severe hepatic dysfunction.
What if you forget to take Bylenta 40mg Tablet :
Omit any missed Bylenta 40mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Bylenta 40mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Therapy | Heart |
3,018 People bought this recently
